Ménière's disease

Practical Neurology

Volumn 9, Issue 3, 2009, Pages 157-162

  Hamid, Mohamed A ^a  

^a Cleveland Hearing and Balance Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; DEVELOPED COUNTRY; DIFFERENTIAL DIAGNOSIS; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; MENIERE DISEASE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PREVALENCE; SEXUAL DEVELOPMENT; STATISTICS;

ADULT; DEVELOPED COUNTRIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MENIERE DISEASE; MIDDLE AGED; PREVALENCE; SEX CHARACTERISTICS;

EID: 67650162492     PISSN: 14747758     EISSN: 14747766     Source Type: Journal    
DOI: 10.1136/jnnp.2009.176602     Document Type: Article

References (32)

1. Friberg U, Stahle J, Svedberg A. The natural course of Ménière's. Acta Otolaryngol Suppl1984;406:72-7.
2. Stahle J, Friberg U, Svedberg A. Long-term progression of Ménière's. Acta Otolaryngol Suppl 1991;485:78-83.
3. Hughes GB, Barna BP, Kinney SE, et al. Autoimmune endolymphatic hydrops: five-year review. Otolaryngol Head Neck Surg 1988;98:221-5.
4. Frykholm C, Larsen HC, Dahl N, et al. Familial Ménière's in five generations. Otol Neurotol2006;27:681-6.
5. Klar J, Frykholm C, Friberg U, et al. A Ménière's gene linked to chromosome 12p12.3. Am J Med Genet B Neuropsychiatr Genet2006;141B:463-7.
6. Stephens D, Kentala E, Varpa K, et al. Positive experiences associated with Me'nière's disorder. Otol Neurotol 2007;28:982-7.
7. Watanabe Y, Mizukoshi K, Shojaku H, et al. Epidemiological and clinical characteristics of Ménière's in Japan. Acta Otolaryngol Suppl1995;519:206-10.
8. Hinchcliffe R. Emotion as a precipitating factor in Méniè re's. J Laryngol Otol 1967;81:471-5.
9. Me'nière's P. Pathologie auricularie: memoire sur des lesions de l'oreille interne donnant lieu a des symptomes de congestion cerebrate apoplectiforme. [abstract]. Gaz Med Paris1861;16:597-601.
10. Yamakawa K. Uber die pathologische Veranderung bei einem Meniere-Kranken [abstract]. L Otorhinolaryngol Spc Jpn 1938;44:2310-12.
11. Hallpike CS, Cairns H. Observations on the pathology of Me'nière's syndrome [abstract]. J Laryngol Otol 1938;53:625-55.
12. Schuknecht HF, Gulya AJ. Endolymphatic hydrops. An overview and classification. Ann Otol Rhinol Laryngol Suppl 1983;106:1-20.
13. Rauch SD, Merchant SN, Thedinger BA. Me'nière's syndrome and endolymphatic hydrops. Doubleblind temporal bone study. Ann Otol Rhinol Laryngol 1989;98:873-83.
14. Nin F, Hibino H, Doi K, et al. The endocochlear potential depends on two K+ diffusion potentials and an electrical barrier in the stria vascularis of the inner ear. Proc Natl Acad Sci USA2008;105:1751-6.
15. Torok N. Old and new in Me'nière disease. Laryngoscope 1977;87:1870-7.
16. Schmidt PH, Brunsting RC, Antvelink JB. Ménière's: etiology and natural history. Acta Otolaryngol 1979;87:410-12.
17. Charachon R, Gratacap B, Barthez M, et al. [Natural history of Ménière's concerning 92 cases from 1971 to 1980]. Rev Laryngol Otol Rhinol (Bord) 1989;110:453-6.
18. Silverstein H, Smouha E, Jones R. Natural history vs. surgery for Ménière's. Otolaryngol Head Neck Surg 1989;100:6-16.
19. Green JD Jr, Blum DJ, Harner SG. Longitudinal follow up of patients with Ménière's. Otolaryngol Head Neck Surg 1991;104:783-8.
20. Hamid M, Trune D. Issues, indications, and controversies regarding intratympanic steroid perfusion. Curr Opin Otolaryngol Head Neck Surg2008;16:434-40.
21. Monsell EM, Balkany TA, Gates GA, et al. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Ménière's [abstract]. Otolaryngol Head Neck Surg1995;113:181-5
22. Hamid M, Sismanis A. Clinical Approach to Patients with Auditory and Vestibular Disorders. In: Hamid M, Sismanis A, eds. Medical otology and neurotology. A clinical guide to auditory and vestibular disorders. New York: Thieme, 2006:43- 63.
23. Neuhauser HK, Lempert T. Diagnostic criteria for migrainous vertigo. Acta Otolaryngol2005;125:1247-8.
24. Smith WK, Sankar V, Pfleiderer AG. A national survey amongst UK otolaryngologists regarding the treatment of Ménière's. J Laryngol Otol2005;119:102-5.
25. Hamid M. Recent advances in medical otologyneurotology. Mediterr J Otol 2005:145-53.
26. Trune DR, Kempton JB, Gross ND. Mineralocorticoid receptor mediates glucocorticoid treatment effects in the autoimmune mouse ear. Hear Res2006;212:22-32.
27. Keles E, Godekmerdan A, Kalidag T, et al. Ménière's and allergy: allergens and cytokines. J Laryngol Otol 2004;118:688-93.
28. Della PC, Guidetti G, Eandi M. Betahistine in the treatment of vertiginous syndromes: a metaanalysis. Acta Otorhinolaryngol Ital 2006;26:208- 15.
29. Bodmer D, Morong S, Stewart C, et al. Long-term vertigo control in patients after intratympanic gentamicin instillation for Méniè re's. Otol Neurotol 2007;28:1140-4.
30. Silverstein H, Lewis WB, Jackson LE, et al. Changing trends in the surgical treatment of Ménière's: results of a 10-year survey. Ear Nose Throat J 2003;82:185-4.
31. Chia SH, Gamst AC, Anderson JP, et al. Intratympanic gentamicin therapy for Ménière's: a meta-analysis. Otol Neurotol2004;25:544-52.
32. Hillman TA, Chen DA, Arriaga MA. Vestibular nerve section versus intratympanic gentamicin for Ménière's. Laryngoscope 2004;114:216-22.